Skip to main content
. 2020 Oct 15;10:554331. doi: 10.3389/fonc.2020.554331

FIGURE 3.

FIGURE 3

The significance of CHST4 in the clinical prognosis of human tumors. (A–L) Kaplan–Meier analysis of the overall survival and disease-free survival in patients with ACC, adrenocortical carcinoma; KIRC, kidney renal clear cell carcinoma; LIHC, liver hepatocellular carcinoma; SKCM, skin cutaneous melanoma; MESO, mesothelioma; KIRP, kidney renal papillary cell carcinoma; UCEC, uterine corpus endometrial carcinoma; BLCA, bladder urothelial carcinoma, and GBM, glioblastoma multiforme using the GEPIA database. The division of CHST4 high and low expression is based on the median (50%) of CHST4 expression in each tumor type.